Article Versions Notes

Lobo J, Guimarães-Teixeira C, Barros-Silva D, Miranda-Gonçalves V, Camilo V, Guimarães R, Cantante M, Braga I, Maurício J, Oing C, et al. Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors. Cancers. 2020; 12(10):2903. https://doi.org/10.3390/cancers12102903

Lobo, João, Catarina Guimarães-Teixeira, Daniela Barros-Silva, Vera Miranda-Gonçalves, Vânia Camilo, Rita Guimarães, Mariana Cantante, Isaac Braga, Joaquina Maurício, Christoph Oing, and et al. 2020. "Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors" Cancers 12, no. 10: 2903. https://doi.org/10.3390/cancers12102903

Lobo, J., Guimarães-Teixeira, C., Barros-Silva, D., Miranda-Gonçalves, V., Camilo, V., Guimarães, R., Cantante, M., Braga, I., Maurício, J., Oing, C., Honecker, F., Nettersheim, D., Looijenga, L. H. J., Henrique, R., & Jerónimo, C. (2020). Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors. Cancers, 12(10), 2903. https://doi.org/10.3390/cancers12102903